Analyte Sensors Comprising Thickeners, Enzyme Stabilizers and Osmium Boronates

• US 20120138484A1
• Filed: 11/16/2011
• Published: 06/07/2012
• Est. Priority Date: 12/03/2010
• Status: Abandoned Application

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Bommakanti, Balasubrahmanya S., Hoss, Udo, Sandhu, Gary
• Application Number:
  US13/298,020
• Publication Number:
  US 20120138484A1
• Time in Patent Office: Days
• US Class Current: 205/777.5
• CPC Class Codes: C12Q 1/006 for glucose

Abstract

Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have improved uniformity of distribution and/or improved sensitivity and/or reduced sensitivity variation of the sensing layer by inclusion of a thickener and/or an enzyme stabilizer in the sensing layer. Embodiments of the present disclosure also relate to transition metal complexes having at least one pyridine boronic acid ligand are also described. Aspects of the disclosure include transition metal complexes chemically bonded to a polymer, such as a sensing layer polymer. The sensing layer is disposed on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.

Claims

1. An analyte sensor comprising:

a working electrode;

a counter electrode; and

a sensing layer disposed on the working electrode, wherein the sensing layer comprises an analyte-responsive enzyme, a redox mediator and a thickener comprising one or more of urea, a urea derivative, urethane, a urethane derivative, a polyvinyl pyrrolidone polymer and a polyvinyl pyrrolidone polymer derivative.

2. The analyte sensor of claim 1, wherein at least a portion of the analyte sensor is adapted to be subcutaneously positioned in a subject.

3. The analyte sensor of claim 1, wherein the sensing layer has an arcuate profile as measured using a profilometer.

4. The analyte sensor of claim 1, wherein the analyte sensor has a sensitivity that is 90% or more of its initial sensitivity after 14 days or more.

5. The analyte sensor of claim 1, wherein the analyte sensor has an average response time that is 35% or more lower than the average response time of a sensor that does not include a thickener.

6. The analyte sensor of claim 1, wherein the analyte-responsive enzyme and the redox mediator are distributed throughout the sensing layer.

7. The analyte sensor of claim 1, further comprising a membrane disposed over the sensing layer, wherein the membrane limits flux of analyte to the sensing layer.

8. The analyte sensor of claim 7, wherein only the sensing layer comprises the thickener.

9. The analyte sensor of claim 1, wherein the analyte sensor is a glucose sensor.

10. The analyte sensor of claim 9, wherein the analyte-responsive enzyme comprises a glucose-responsive enzyme.

11. The analyte sensor of claim 10, wherein the glucose-responsive enzyme comprises glucose oxidase.

12. The analyte sensor of claim 9, wherein the redox mediator comprises a ruthenium-containing complex or an osmium-containing complex.

13. The analyte sensor of claim 1, wherein the analyte sensor is an in vivo sensor.

14. The analyte sensor of claim 1, wherein the analyte sensor is an in vitro sensor.

15. A method for monitoring a level of an analyte in a subject, the method comprising:

positioning at least a portion of an analyte sensor into skin of a subject, wherein the analyte sensor comprises;

a working electrode;

a counter electrode; and

a sensing layer disposed on the working electrode, wherein the sensing layer comprises an analyte-responsive enzyme, a redox mediator and a thickener comprising one or more of urea, a urea derivative, urethane, a urethane derivative, a polyvinyl pyrrolidone polymer and a polyvinyl pyrrolidone polymer derivative, and

determining a level of an analyte over a period of time from signals generated by the analyte sensor,

wherein the determining over a period of time provides for monitoring the level of the analyte in the subject.

16. The method of claim 15, wherein the sensing layer has an arcuate profile as measured using a profilometer.

17. The method of claim 15, wherein the analyte sensor has a sensitivity that is 90% or more of its initial sensitivity after 14 days or more.

18. The method of claim 15, wherein the analyte sensor has an average response time that is 35% or more lower than the average response time of a sensor that does not include a thickener.

19. The method of claim 15, wherein the analyte-responsive enzyme and the redox mediator are distributed throughout the sensing layer.

20. The method of claim 15, wherein the analyte sensor further comprises a membrane disposed over the sensing layer, wherein the membrane limits flux of the analyte to the sensing layer.

21. The method of claim 20, wherein only the sensing layer comprises the thickener.

22. The method of claim 15, wherein the analyte sensor is a glucose sensor.

23. The method of claim 22, wherein the analyte-responsive enzyme comprises a glucose-responsive enzyme.

24. The method of claim 23, wherein the glucose-responsive enzyme comprises glucose oxidase.

25. The method of claim 22, wherein the redox mediator comprises a ruthenium-containing complex or an osmium-containing complex.

26. A method for monitoring a level of an analyte using an analyte monitoring system, the method comprising:

inserting at least a portion of an analyte sensor into skin of a patient, the analyte sensor comprising;

a working electrode;

a counter electrode; and

a sensing layer disposed on the working electrode, wherein the sensing layer comprises an analyte-responsive enzyme, a redox mediator and a thickener comprising one or more of urea, a urea derivative, urethane, a urethane derivative, a polyvinyl pyrrolidone polymer and a polyvinyl pyrrolidone polymer derivative;

attaching an analyte sensor control unit to the skin of the patient;

coupling a plurality of conductive contacts of the analyte sensor control unit to a plurality of contact pads of the analyte sensor;

collecting data, using the analyte sensor control unit, regarding a level of an analyte from signals generated by the analyte sensor; and

transmitting the collected data from the analyte sensor control unit to a receiver unit.

27. The method of claim 26, wherein the sensing layer has an arcuate profile as measured using a profilometer.

28. The method of claim 26, wherein the analyte sensor has a sensitivity that is 90% or more of its initial sensitivity after 14 days or more.

29. The method of claim 26, wherein the analyte sensor has an average response time that is 35% or more lower than the average response time of a sensor that does not include a thickener.

30. The method of claim 26, wherein the analyte is glucose.

31. The method of claim 26, wherein the collecting data comprises generating signals from the analyte sensor and processing the signals into data.

32. The method of claim 26, wherein the data comprise the signals from the analyte sensor.

33. The method of claim 26, further comprising activating an alarm if the data indicate an alarm condition.

34. The method of claim 26, further comprising administering a drug in response to the data.

35. The method of claim 34, wherein the drug is insulin.

36. The method of claim 26, further comprising obtaining a calibration value from a calibration device to calibrate the data.

37. The method of claim 36, wherein the calibration device is coupled to a display unit.

38. The method of claim 37, further comprising transmitting the calibration value from a transmitter in the display unit to a receiver in the analyte sensor control unit.

39. A method of fabricating an electrode for use in an analyte sensor, the method comprising:

contacting an electrode with a sensing layer, wherein the sensing layer comprises an analyte-responsive enzyme, a redox mediator and a thickener comprising one or more of urea, a urea derivative, urethane, a urethane derivative, a polyvinyl pyrrolidone polymer and a polyvinyl pyrrolidone polymer derivative.

40. The method of claim 39, wherein the sensing layer has an arcuate profile as measured using a profilometer.

41. The method of claim 39, wherein the analyte sensor has a sensitivity that is 90% or more of its initial sensitivity after 14 days or more.

42. The method of claim 39, wherein the analyte sensor has an average response time that is 35% or more lower than the average response time of a sensor that does not include a thickener.

43. The method of claim 39, wherein the analyte-responsive enzyme and the redox mediator are distributed throughout the sensing layer.

44. The method of claim 39, further comprising contacting the sensing layer with a membrane that limits flux of the analyte to the sensing layer, wherein the membrane is disposed over the sensing layer.

45. The method of claim 44, wherein only the sensing layer comprises the thickener.

46. The method of claim 39, wherein the analyte sensor is a glucose sensor.

47. The method of claim 46, wherein the analyte-responsive enzyme comprises a glucose-responsive enzyme.

48. The method of claim 47, wherein the glucose-responsive enzyme comprises glucose oxidase.

49. The method of claim 46, wherein the redox mediator comprises a ruthenium-containing complex or an osmium-containing complex.

50. The method of claim 39, wherein the analyte sensor is an in vivo sensor.

51. The method of claim 39, wherein the analyte sensor is an in vitro sensor.

52-103. -103. (canceled)